Evidence map›Paper›PMID 40780533›Full record

ReviewToxicology and applied pharmacology2025

Carcinogenicity of some metals evaluated by the IARC Monographs: A synopsis of the evaluations of arsenic, cadmium, cobalt, and antimony.

Aline de Conti, Federica Madia, Mary K Schubauer-Berigan, Lamia Benbrahim-Tallaa

Abstract readReview
In one paragraph

Review in Toxicology and applied pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Long-term exposure to PMAir quality, atmosphere, & health · 2026
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Aline de ContiInternational Agency for Research on Cancer (IARC/WHO), Evidence Synthesis and Classification Branch, Lyon, France. Electronic address: decontia@iarc.who.int.
Federica MadiaInternational Agency for Research on Cancer (IARC/WHO), Evidence Synthesis and Classification Branch, Lyon, France.
Mary K Schubauer-BeriganInternational Agency for Research on Cancer (IARC/WHO), Evidence Synthesis and Classification Branch, Lyon, France.
Lamia Benbrahim-TallaaInternational Agency for Research on Cancer (IARC/WHO), Evidence Synthesis and Classification Branch, Lyon, France.

Funding

IARC Monographs on the Identification of Carcinogenic Hazards to HumansR01CA033193 · NCI · INTERNATIONAL AGENCY FOR RES ON CANCER · PI SCHUBAUER-BERIGAN, MARY K. · 2021 to 2025
$4.9M
NCI NIH HHS R01 CA033193World Health Organization 001
6 · The paper itself

Abstract

Metals represent a major area of concern due to their extensive industrial applications, environmental persistence, and well-documented adverse health effects. Notably, metals (and metalloids) such as arsenic, cadmium, beryllium, chromium, cobalt, lead, and nickel are known for their toxicity and carcinogenic potential, raising significant public health concerns. Human exposure to these metals occurs through different routes, posing both environmental and workplace hazards. The Monographs programme of the International Agency for Research on Cancer (IARC) plays a critical role in identifying carcinogenic hazards to humans, providing a robust scientific foundation for global actions to prevent cancer. This review focuses on selected metals and metalloids: arsenic, cadmium, cobalt, and antimony, emphasizing how the IARC evaluation process considers the biological properties of the metals and their compounds, and the evidence from experimental animal studies and mechanistic data, including the application of the key characteristics of carcinogens (KCs) framework, in determining carcinogenic potential. The IARC Monographs contribute to a comprehensive understanding of metal-induced carcinogenicity and reinforce the importance of systematic, evidence-based approaches to inform public health interventions and regulatory decision-making.

Indexed as

AntimonyArsenicCadmiumCarcinogensCobaltNeoplasmsAnimalsCarcinogenicity TestsHumansRisk AssessmentAntimonyArsenicCadmiumCarcinogensCobaltAntimonyArsenicCadmiumCancerCobaltMechanismsMetals

Identifiers

PMID40780533
PMCPMC13522431

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.